ValuationViz

KRYS fund manager activity

Krystal Biotech, Inc · Nasdaq. Reported by 3 tracked fund managers in their 13F filings, Q1 2023 to Q2 2026.

Q2 2026

ManagerActivitySharesValue% of portfolioFiled
Ken Fisher - Fisher Asset ManagementTrimmed27,676$10,286,5870.00%Aug 4, 2026
Joel Greenblatt - Gotham Asset ManagementAdded1,330$494,3210.00%Aug 14, 2026
Torray FundsAdded12,156$4,518,0210.61%Jul 30, 2026

Q1 2026

ManagerActivitySharesValue% of portfolioFiled
Ken Fisher - Fisher Asset ManagementAdded27,784$7,177,3340.00%May 5, 2026
Joel Greenblatt - Gotham Asset ManagementAdded1,323$341,7570.00%May 15, 2026
Torray FundsAdded12,032$3,108,1060.46%May 1, 2026

Older quarters